• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用 [H]CS1P1 和 [C]CS1P1 研究 S1PR1 在中枢神经系统中的表达。

and Investigation of S1PR1 Expression in the Central Nervous System Using [H]CS1P1 and [C]CS1P1.

机构信息

Department of Radiology, Washington University School of Medicine, St Louis, Missouri 63110, United States.

Department of Neurology, Washington University School of Medicine, St Louis, Missouri 63110, United States.

出版信息

ACS Chem Neurosci. 2021 Oct 6;12(19):3733-3744. doi: 10.1021/acschemneuro.1c00492. Epub 2021 Sep 13.

DOI:10.1021/acschemneuro.1c00492
PMID:34516079
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8605766/
Abstract

Sphingosine-1-phosphate receptor 1 (S1PR1) is ubiquitously expressed among all tissues and plays key roles in many physiological and cellular processes. In the central nervous system (CNS), S1PR1 is expressed in different types of cells including neurons, astrocytes, and oligodendrocyte precursor cells. S1PR1 has been recognized as a novel therapeutic target in multiple sclerosis and other diseases. We previously reported a promising S1PR1-specific radioligand, [C]CS1P1 (previously named [C]TZ3321), which is under clinical investigation for human use. In the current study, we performed a detailed characterization of [H]CS1P1 for its binding specificity to S1PR1 in CNS using autoradiography and immunohistochemistry in human and rat CNS tissues. Our data indicate that [H]CS1P1 binds to S1PR1 in human frontal cortex tissue with a of 3.98 nM and a of 172.5 nM. The distribution of [H]CS1P1 in human and rat CNS tissues is consistent with the distribution of S1PR1 detected by immunohistochemistry studies. Our microPET studies of [C]CS1P1 in a nonhuman primate (NHP) show a standardized uptake value of 2.4 in the NHP brain, with test-retest variability of 0.23% among six different NHPs. Radiometabolite analysis in the plasma samples of NHP and rat, as well as in rat brain samples, showed that [C]CS1P1 was stable . Kinetic modeling studies using a two-compartment tissue model showed that the positron emission tomography (PET) data fit the model well. Overall, our study provides a detailed characterization of [H]CS1P1 binding to S1PR1 in the CNS. Combined with our microPET studies in the NHP brain, our data suggest that [C]CS1P1 is a promising radioligand for PET imaging of S1PR1 in the CNS.

摘要

鞘氨醇-1-磷酸受体 1(S1PR1)在所有组织中广泛表达,在许多生理和细胞过程中发挥关键作用。在中枢神经系统(CNS)中,S1PR1 表达于包括神经元、星形胶质细胞和少突胶质细胞前体细胞在内的不同类型的细胞中。S1PR1 已被认为是多发性硬化症和其他疾病的新的治疗靶点。我们之前报道了一种有前途的 S1PR1 特异性放射性配体 [C]CS1P1(以前称为 [C]TZ3321),目前正在进行人体临床试验。在本研究中,我们使用放射自显影和免疫组织化学技术,在人源和大鼠 CNS 组织中对 [H]CS1P1 与 S1PR1 的结合特异性进行了详细表征。我们的数据表明,[H]CS1P1 与人前额皮质组织中的 S1PR1 结合的 为 3.98 nM, 为 172.5 nM。[H]CS1P1 在人源和大鼠 CNS 组织中的分布与免疫组织化学研究检测到的 S1PR1 分布一致。我们在非人类灵长类动物(NHP)中进行的 [C]CS1P1 的 microPET 研究显示,NHP 大脑中的标准化摄取值为 2.4,6 只不同 NHP 之间的测试-复测变异性为 0.23%。在 NHP 和大鼠的血浆样本以及大鼠脑组织样本中的放射性代谢产物分析表明,[C]CS1P1 稳定。使用双室组织模型进行的动力学建模研究表明,正电子发射断层扫描(PET)数据与模型拟合良好。总体而言,我们的研究提供了 [H]CS1P1 与 CNS 中 S1PR1 结合的详细特征。结合我们在 NHP 大脑中的 microPET 研究,我们的数据表明,[C]CS1P1 是一种很有前途的 S1PR1 在 CNS 中的 PET 成像放射性配体。

相似文献

1
and Investigation of S1PR1 Expression in the Central Nervous System Using [H]CS1P1 and [C]CS1P1.利用 [H]CS1P1 和 [C]CS1P1 研究 S1PR1 在中枢神经系统中的表达。
ACS Chem Neurosci. 2021 Oct 6;12(19):3733-3744. doi: 10.1021/acschemneuro.1c00492. Epub 2021 Sep 13.
2
Design, synthesis, and biological evaluation of multiple F-18 S1PR1 radiotracers in rodent and nonhuman primate.设计、合成及 F-18 S1PR1 放射性示踪剂在啮齿类动物和非人灵长类动物中的生物学评价。
Org Biomol Chem. 2024 Jul 3;22(26):5428-5453. doi: 10.1039/d4ob00712c.
3
Metabolite Study and Structural Authentication for the First-in-Human Use Sphingosine-1-phosphate Receptor 1 Radiotracer.用于首次人体使用的鞘氨醇-1-磷酸受体 1 放射性示踪剂的代谢产物研究和结构鉴定。
ACS Chem Neurosci. 2024 May 1;15(9):1882-1892. doi: 10.1021/acschemneuro.4c00077. Epub 2024 Apr 18.
4
Identification of a Putative α-synuclein Radioligand Using an in silico Similarity Search.利用计算机模拟相似性搜索鉴定潜在的α-突触核蛋白放射性配体。
Mol Imaging Biol. 2023 Aug;25(4):704-719. doi: 10.1007/s11307-023-01814-9. Epub 2023 Mar 29.
5
PET Imaging of Sphingosine-1-Phosphate Receptor 1 with [F]TZ4877 in Nonhuman Primates.用[F]TZ4877对非人灵长类动物进行1-磷酸鞘氨醇受体1的正电子发射断层显像。
Mol Imaging Biol. 2025 Feb;27(1):54-63. doi: 10.1007/s11307-024-01979-x. Epub 2025 Jan 8.
6
Quantitative Analysis of S1PR1 Expression in the Postmortem Multiple Sclerosis Central Nervous System.多发性硬化症死后中枢神经系统中 S1PR1 表达的定量分析。
ACS Chem Neurosci. 2023 Nov 15;14(22):4039-4050. doi: 10.1021/acschemneuro.3c00581. Epub 2023 Oct 26.
7
Sanleng Wan inhibits endometriosis progression by regulating sphingolipid metabolism via the S1P/S1PR1-Akt axis based on serum metabolomics and network pharmacology.基于血清代谢组学和网络药理学,三棱丸通过S1P/S1PR1-Akt轴调节鞘脂代谢来抑制子宫内膜异位症进展。
J Ethnopharmacol. 2025 Jun 14;352:120153. doi: 10.1016/j.jep.2025.120153.
8
Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphoma.正电子发射断层扫描适配疗法用于霍奇金淋巴瘤患者的一线治疗
Cochrane Database Syst Rev. 2015 Jan 9;1(1):CD010533. doi: 10.1002/14651858.CD010533.pub2.
9
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.用于诊断神经母细胞瘤的123I-间碘苄胍闪烁扫描术和18F-氟代脱氧葡萄糖正电子发射断层显像
Cochrane Database Syst Rev. 2015 Sep 29;2015(9):CD009263. doi: 10.1002/14651858.CD009263.pub2.
10
Interventions for central serous chorioretinopathy: a network meta-analysis.中心性浆液性脉络膜视网膜病变的干预措施:一项网状Meta分析
Cochrane Database Syst Rev. 2025 Jun 16;6(6):CD011841. doi: 10.1002/14651858.CD011841.pub3.

引用本文的文献

1
PET Study of S1PR1 Expression in Rodent Model of Myocardial Infarction.心肌梗死啮齿动物模型中S1PR1表达的正电子发射断层扫描(PET)研究
Mol Imaging Biol. 2025 Aug 6. doi: 10.1007/s11307-025-02039-8.
2
Synthesis and in vivo biological characterization of six carbon-11 sigma-1 receptor radiotracers in rodent and nonhuman primate.六种碳-11 σ-1受体放射性示踪剂在啮齿动物和非人灵长类动物中的合成及体内生物学特性研究
Bioorg Med Chem. 2025 Aug 15;126:118218. doi: 10.1016/j.bmc.2025.118218. Epub 2025 Apr 28.
3
Synthesis and evaluation of 6-arylaminobenzamides as positron emission tomography imaging ligands for the sphingosine-1-phosphate-5 receptor.6-芳基氨基苯甲酰胺作为鞘氨醇-1-磷酸-5受体正电子发射断层显像配体的合成与评价
RSC Med Chem. 2025 Jan 3;16(3):1235-1249. doi: 10.1039/d4md00929k. eCollection 2025 Mar 19.
4
PET Imaging of Sphingosine-1-Phosphate Receptor 1 with [F]TZ4877 in Nonhuman Primates.用[F]TZ4877对非人灵长类动物进行1-磷酸鞘氨醇受体1的正电子发射断层显像。
Mol Imaging Biol. 2025 Feb;27(1):54-63. doi: 10.1007/s11307-024-01979-x. Epub 2025 Jan 8.
5
Dissociation between the anti-allodynic effects of fingolimod (FTY720) and desensitization of S1P receptor-mediated G-protein activation in a mouse model of sciatic nerve injury.在坐骨神经损伤的小鼠模型中,芬戈莫德(FTY720)的抗痛觉过敏作用与 S1P 受体介导的 G 蛋白激活脱敏分离。
Neuropharmacology. 2024 Dec 15;261:110165. doi: 10.1016/j.neuropharm.2024.110165. Epub 2024 Sep 18.
6
PET imaging of neuroinflammation: any credible alternatives to TSPO yet?神经炎症的正电子发射断层显像(PET)成像:目前是否有比转运蛋白18 kDa(TSPO)更可靠的替代物?
Mol Psychiatry. 2025 Jan;30(1):213-228. doi: 10.1038/s41380-024-02656-9. Epub 2024 Jul 13.
7
Design, synthesis, and biological evaluation of multiple F-18 S1PR1 radiotracers in rodent and nonhuman primate.设计、合成及 F-18 S1PR1 放射性示踪剂在啮齿类动物和非人灵长类动物中的生物学评价。
Org Biomol Chem. 2024 Jul 3;22(26):5428-5453. doi: 10.1039/d4ob00712c.
8
PET Imaging of Sphingosine-1-Phosphate Receptor 1 with [18F]TZ4877 in Nonhuman Primates.用[18F]TZ4877对非人灵长类动物进行1-磷酸鞘氨醇受体1的正电子发射断层显像
Res Sq. 2024 May 30:rs.3.rs-4350862. doi: 10.21203/rs.3.rs-4350862/v1.
9
Metabolite Study and Structural Authentication for the First-in-Human Use Sphingosine-1-phosphate Receptor 1 Radiotracer.用于首次人体使用的鞘氨醇-1-磷酸受体 1 放射性示踪剂的代谢产物研究和结构鉴定。
ACS Chem Neurosci. 2024 May 1;15(9):1882-1892. doi: 10.1021/acschemneuro.4c00077. Epub 2024 Apr 18.
10
PET Quantification of [F]VAT in Human Brain and Its Test-Retest Reproducibility and Age Dependence.正电子发射断层显像术(PET)对人脑[F]VAT 的定量及其测试-重测的可重复性和年龄依赖性。
J Nucl Med. 2024 Jun 3;65(6):956-961. doi: 10.2967/jnumed.123.266860.

本文引用的文献

1
Post-translational modifications of S1PR1 and endothelial barrier regulation.S1PR1 的翻译后修饰与内皮屏障调节。
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Sep;1865(9):158760. doi: 10.1016/j.bbalip.2020.158760. Epub 2020 Jun 22.
2
Sphingosine 1-phosphate but not Fingolimod protects neurons against excitotoxic cell death by inducing neurotrophic gene expression in astrocytes.鞘氨醇 1-磷酸而不是芬戈莫德通过诱导星形胶质细胞中神经营养基因的表达来防止神经元对抗兴奋毒性细胞死亡。
J Neurochem. 2020 Apr;153(2):173-188. doi: 10.1111/jnc.14917. Epub 2019 Dec 6.
3
Myeloid sphingosine-1-phosphate receptor 1 is important for CNS autoimmunity and neuroinflammation.髓鞘鞘氨醇-1-磷酸受体 1 对于中枢神经系统自身免疫和神经炎症很重要。
J Autoimmun. 2019 Dec;105:102290. doi: 10.1016/j.jaut.2019.06.001. Epub 2019 Jun 12.
4
Sphingosine-1-phosphate receptor 1 activation in astrocytes contributes to neuropathic pain.星形胶质细胞中鞘氨醇-1-磷酸受体 1 的激活有助于神经性疼痛。
Proc Natl Acad Sci U S A. 2019 May 21;116(21):10557-10562. doi: 10.1073/pnas.1820466116. Epub 2019 May 8.
5
Syntheses and in vitro biological evaluation of S1PR1 ligands and PET studies of four F-18 labeled radiotracers in the brain of nonhuman primates.S1PR1 配体的合成及体外生物学评价及四种 F-18 标记放射性示踪剂在非人灵长类动物脑内的 PET 研究。
Org Biomol Chem. 2018 Dec 5;16(47):9171-9184. doi: 10.1039/c8ob02609b.
6
Sphingolipids in neurodegeneration (with focus on ceramide and S1P).神经退行性变中的鞘脂类(重点关注神经酰胺和1-磷酸鞘氨醇)
Adv Biol Regul. 2018 Dec;70:51-64. doi: 10.1016/j.jbior.2018.09.013. Epub 2018 Sep 22.
7
Syntheses and in vitro evaluation of new S1PR1 compounds and initial evaluation of a lead F-18 radiotracer in rodents.新型S1PR1化合物的合成与体外评价以及一种先导F-18放射性示踪剂在啮齿动物中的初步评价。
Eur J Med Chem. 2018 Apr 25;150:796-808. doi: 10.1016/j.ejmech.2018.03.035. Epub 2018 Mar 14.
8
Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis.芬戈莫德对多发性硬化症患者脑灰质、丘脑和白质的影响。
Neurology. 2018 Apr 10;90(15):e1324-e1332. doi: 10.1212/WNL.0000000000005292. Epub 2018 Mar 14.
9
Sphingosine 1-Phosphate Receptor Subtype 1 as a Therapeutic Target for Brain Trauma.鞘氨醇 1-磷酸受体亚型 1 作为脑创伤的治疗靶点。
J Neurotrauma. 2018 Jul 1;35(13):1452-1466. doi: 10.1089/neu.2017.5391. Epub 2018 Apr 17.
10
Upregulated Sphingosine 1-Phosphate Receptor 1 Expression in Human and Murine Atherosclerotic Plaques.上调的人及鼠动脉粥样硬化斑块中鞘氨醇 1-磷酸受体 1 的表达。
Mol Imaging Biol. 2018 Jun;20(3):448-456. doi: 10.1007/s11307-017-1141-3.